Minervax
PrivateLast Round
Series B
Extension
Oct 11, 2023
Est. Valuation
$7.91M
Total Funding Raised
$145M
Momentum Score
25 /100
Company Overview
MinervaX is a biotechnology company focused on developing maternal vaccines aimed at preventing adverse pregnancy outcomes and life-threatening infections caused by group B streptococcus.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery
Business Model
B2G
Customer Profile
Government Contracts, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Minervax Comps
Public and private peers based on sector, stage, and business model.
Minervax Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B Extension | Oct 11, 2023 | ||||
| Series B Extension | Dec 15, 2022 | ||||
| Series B | Dec 15, 2020 | ||||
| Grant | Jan 21, 2019 | ||||
| Series A Extension | Feb 15, 2016 |
Key People
Founding team and executive leadership
Minervax Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Heartcore Capital | Seed, Series A Extension |
| REPAIR Impact Fund | Grant, Series B |
| EQT Life Sciences | Series B Extension |
| Trill Impact | Series B Extension |
| Novo Seeds | Series A Extension, Series B |
| Lund University Innovation System | Seed |
| LF Investment | Series B Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 17, 2026
Monthly visitors grew 212% MoM.
- Apr 15, 2026
Hans Henrik Chrois Christensen appointed as Chief Financial Officer.
Minervax Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Minervax's valuation, stock price, and market status.
